Burst Optimized Stimulation Study

NCT ID: NCT02896361

Last Updated: 2019-05-30

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

29 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This purpose of this study is to evaluate the therapeutic efficacy of burst microdosing stimulation paradigms in patients with chronic pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multicenter, randomized, double-blinded crossover study designed to compare conventional burst stimulation parameters to two different burst microdosing paradigms.

Subjects will be randomized 1:1:1 to one of the three groups. Each group will evaluate all 3 stimulation paradigms in different order.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stimulation order 1

Stimulations delivered in following order:

1. Standard burst
2. Burst Microdosing 1
3. Burst Microdosing 2

Group Type EXPERIMENTAL

Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol

Intervention Type DEVICE

Stimulation parameters are reprogrammed from original values to study defined ones

Stimulation order 2

Stimulations delivered in following order:

1. Burst Microdosing 1
2. Burst Microdosing 2
3. Standard burst

Group Type EXPERIMENTAL

Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol

Intervention Type DEVICE

Stimulation parameters are reprogrammed from original values to study defined ones

Stimulation order 3

Stimulations delivered in following order:

1. Burst Microdosing 2
2. Standard burst
3. Burst Microdosing 1

Group Type EXPERIMENTAL

Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol

Intervention Type DEVICE

Stimulation parameters are reprogrammed from original values to study defined ones

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol

Stimulation parameters are reprogrammed from original values to study defined ones

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has been implanted with a commercially available SJM spinal cord stimulator for controlling chronic intractable pain associated with back and/or leg pain;
* Subject has been exclusively using burst stimulation for at least three months;
* Subject is 18 years of age or older;
* Subject's pain-related medication regimen was stable in the 4 weeks prior to the screening evaluation;
* Subject agrees not to add or increase pain-related medication from enrollment through the study duration;
* Subject is willing to cooperate with the study requirements including compliance with the regimen and completion of all office visits;

Exclusion Criteria

* Subject is currently participating in a clinical investigation study that includes an active treatment arm;
* Subject is currently receiving, applying or considering seeking workers compensation, or is involved in disability litigation;
* Subject has a non SJM neuromodulation device
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medizinische Einrichtungen der Universität Düsseldorf

UNKNOWN

Sponsor Role collaborator

Klinikum Duisburg GmbH

UNKNOWN

Sponsor Role collaborator

NKO Sint-Augustinus Antwerpen

UNKNOWN

Sponsor Role collaborator

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lalit Venkatesan, Ph.D.

Role: STUDY_DIRECTOR

Abbott Medical Devices

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NKO Sint-Augustinus

Antwerp, , Belgium

Site Status

Klinikum Duisburg GmbH

Duisburg, North Rhine-Westphalia, Germany

Site Status

Medizinische Einrichtungen der Universität Düsseldorf

Düsseldorf, North Rhine-Westphalia, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Germany

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SJM-CIP-10125

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Titration Study of ABX-1431
NCT03447756 COMPLETED PHASE1
Central Pain Study for ABX-1431
NCT03138421 COMPLETED PHASE1